Paradoxical Elevation of Parathyroid Hormone Levels following Preoperative Native Vitamin D Supplementation in a Patient with Graves’ Disease Undergoing Total Thyroidectomy: A Case Report
Open Access
- 1 January 2025
- journal article
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 11 (1) , cr.25-0465
Abstract
INTRODUCTION: Hypocalcemia is a common complication after total thyroidectomy, particularly in patients with Graves’ disease and high bone turnover. Preoperative vitamin D deficiency is a known risk factor for postoperative hypocalcemia; however, the effects of vitamin D supplementation remain controversial. This is the first study to document a paradoxical increase in parathyroid hormone (PTH) levels after preoperative vitamin D supplementation in a patient undergoing total thyroidectomy.CASE PRESENTATION: We report the case of a 68-year-old woman with Graves’ disease and coexisting thyroid cancer who received native vitamin D (2000 IU/day) for 4 weeks before surgery. This unexpectedly resulted in a marked increase in PTH levels and bone formation markers, suggesting the worsening of secondary hyperparathyroidism. Interestingly, fibroblast growth factor 23 levels remained unchanged despite an increase in PTH and 1,25-dihydroxyvitamin D levels. Postoperatively, she developed transient hypoparathyroidism.CONCLUSIONS: Native vitamin D supplementation may, paradoxically, worsen secondary hyperparathyroidism in some patients, highlighting the need for careful preoperative metabolic assessment and individualized management strategies.Keywords
This publication has 11 references indexed in Scilit:
- Significant role of 1,25-dihydroxyvitamin D on serum calcium levels after total thyroidectomy: a prospective cohort studyFrontiers in Endocrinology, 2024
- A prospective cross-sectional study on hypocalcemia after total thyroidectomy in patients with Graves’ disease: insights on secondary hyperparathyroidismSurgery Today, 2024
- Evaluating the effect of vitamin D supplementation on serum levels of 25-hydroxy vitamin D, 1,25-dihydroxy vitamin D, parathyroid hormone and renin–angiotensin–aldosterone system: a systematic review and meta-analysis of clinical trialsBMC Nutrition, 2023
- Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTsDiseases, 2023
- The role of preoperative vitamin D and calcium in preventing post-thyroidectomy hypocalcaemia: a systematic reviewEuropean Archives of Oto-Rhino-Laryngology, 2022
- Vitamin D and bone metabolism in Graves’ disease: a prospective studyJournal of Endocrinological Investigation, 2022
- Post-thyroidectomy hypocalcemia: Is a routine preferable over a selective supplementation?The American Journal of Surgery, 2022
- FGF23 and Vitamin D MetabolismJBMR Plus, 2021
- MANAGEMENT OF ENDOCRINE DISEASE: Postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantationEuropean Journal of Endocrinology, 2021
- Post-Operative Permanent Hypoparathyroidism and Preoperative Vitamin D ProphylaxisJournal of Clinical Medicine, 2021